Each 120 mg vial of IMFINZI contains 120 mg of durvalumab in 2.4 mL solution.
Each 500 mg vial of IMFINZI contains 500 mg of durvalumab in 10 mL solution.
Durvalumab is a programmed cell death ligand 1 (PD-L1) blocking antibody. Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that is produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture.
IMFINZI (durvalumab) CONCENTRATE FOR SOLUTION FOR INFUSION is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow solution, free from visible particles.
Excipients/Inactive Ingredients: Each mL contains L-histidine (2 mg), L-histidine hydrochloride monohydrate (2.7 mg), α,α-trehalose dihydrate (104 mg), Polysorbate 80 (0.2 mg), and Water for Injection.